{"transactions":[{"id":2304254,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-04-05T08:17:04.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":1091,"price":1.25,"value":1363.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":68330,"source":{"system":"sec-edgar","filing":"0001457612-22-000044","document":"wf-form4_164916101204761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000044/wf-form4_164916101204761.xml","form_type":"4"}},{"id":2327191,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-17T16:09:09.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are scheduled to vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":93750,"derivative":{"exercise_price":1.11,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001457612-22-000028","document":"wf-form4_164754772688295.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000028/wf-form4_164754772688295.xml","form_type":"4"}},{"id":2327190,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-03-17T16:09:09.000Z","date":"2022-03-16","kind":"sale","acquired":false,"shares":2717,"price":1.1,"value":2988.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":69421,"source":{"system":"sec-edgar","filing":"0001457612-22-000028","document":"wf-form4_164754772688295.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000028/wf-form4_164754772688295.xml","form_type":"4"}},{"id":2327189,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-03-17T16:09:09.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date."}],"balance_after":72138,"source":{"system":"sec-edgar","filing":"0001457612-22-000028","document":"wf-form4_164754772688295.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000028/wf-form4_164754772688295.xml","form_type":"4"}},{"id":2330679,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-03-16T17:29:45.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":524,"price":2.23,"value":1168.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":48700,"source":{"system":"sec-edgar","filing":"0001457612-22-000018","document":"wf-form5_164746616934998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000018/wf-form5_164746616934998.xml","form_type":"5"}},{"id":2330678,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-03-16T17:29:45.000Z","date":"2021-04-02","kind":"sale","acquired":false,"shares":948,"price":2.71,"value":2569.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":49224,"source":{"system":"sec-edgar","filing":"0001457612-22-000018","document":"wf-form5_164746616934998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000018/wf-form5_164746616934998.xml","form_type":"5"}},{"id":2782043,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2021-03-17T13:50:57.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vesting of these restricted stock units depends on the average closing price of a share of Genocea Biosciences, Inc.'s common stock over the sixty trading days immediately preceding December 31, 2023. The\"target\" number of restricted stock units is reported. Between 75% and 150% of the target number of units may vest on December 31, 2023, with the vesting percentage determined based on actual performance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vesting of these restricted stock units depends on the average closing price of a share of Genocea Biosciences, Inc.'s common stock over the sixty trading days immediately preceding December 31, 2023. The\"target\" number of restricted stock units is reported. Between 75% and 150% of the target number of units may vest on December 31, 2023, with the vesting percentage determined based on actual performance."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001457612-21-000034","document":"wf-form4_161600344570799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000034/wf-form4_161600344570799.xml","form_type":"4"}},{"id":2782042,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T13:50:57.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are scheduled to vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":93750,"derivative":{"exercise_price":3.01,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001457612-21-000034","document":"wf-form4_161600344570799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000034/wf-form4_161600344570799.xml","form_type":"4"}},{"id":2782041,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2021-03-17T13:50:57.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date."}],"balance_after":31250,"source":{"system":"sec-edgar","filing":"0001457612-21-000034","document":"wf-form4_161600344570799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000034/wf-form4_161600344570799.xml","form_type":"4"}},{"id":3126932,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T16:24:20.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":24938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":24938,"derivative":{"exercise_price":2.72,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":24938},"source":{"system":"sec-edgar","filing":"0001457612-20-000082","document":"wf-form4_159112944346474.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000082/wf-form4_159112944346474.xml","form_type":"4"}},{"id":3126931,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2020-06-02T16:24:20.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":6623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Amended and Restated 2014 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest one-fourth (1/4) on each of the first four (4) anniversaries on the date of grant."}],"balance_after":6623,"source":{"system":"sec-edgar","filing":"0001457612-20-000082","document":"wf-form4_159112944346474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000082/wf-form4_159112944346474.xml","form_type":"4"}},{"id":3181599,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-06T16:18:41.000Z","date":"2020-04-02","kind":"grant","acquired":true,"shares":46313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":46313,"derivative":{"exercise_price":1.66,"expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":46313},"source":{"system":"sec-edgar","filing":"0001457612-20-000031","document":"wf-form4_158620430362691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000031/wf-form4_158620430362691.xml","form_type":"4"}},{"id":3181598,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2020-04-06T16:18:41.000Z","date":"2020-04-02","kind":"grant","acquired":true,"shares":12299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Amended and Restated 2014 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest one-fourth (1/4) on each of the first four (4) anniversaries on the date of grant."}],"balance_after":12299,"source":{"system":"sec-edgar","filing":"0001457612-20-000031","document":"wf-form4_158620430362691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000031/wf-form4_158620430362691.xml","form_type":"4"}},{"id":3665832,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-11T21:00:13.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest as to 1/4th of the shares subject to the option on the first anniversary of the Grant Date and thereafter as to 1/36th of the shares on each subsequent monthly anniversary of February 7, 2020 (rounded down to the nearest whole share, except for the final vesting period, with respect to which all remaining shares will vest)."}],"balance_after":300000,"derivative":{"exercise_price":0.54,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001457612-19-000016","document":"wf-form4_154993679883544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761219000016/wf-form4_154993679883544.xml","form_type":"4"}},{"id":3801241,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-02T19:25:47.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The Stock Option shall become exercisable as to 25% of the maximum number of shares on October 1, 2019, and as to an additional 2.0833% of the total number of shares on each monthly anniversary thereafter"}],"balance_after":500000,"derivative":{"exercise_price":0.79,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001457612-18-000101","document":"wf-form4_153852273097686.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761218000101/wf-form4_153852273097686.xml","form_type":"4"}},{"id":4280092,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":128287,"kind":"person","name":"Davis Thomas Andrew","position":1,"cik":"0001338185","reported_name":"Davis Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CMO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-06-16T13:27:15.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2018 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":150000,"derivative":{"exercise_price":2.32,"exercise_date":"2018-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-17-009155","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911017009155/edgar.xml","form_type":"4"}}]}